339 related articles for article (PubMed ID: 21696985)
1. Circulating cytokine concentrations in dogs with different degrees of myxomatous mitral valve disease.
Zois NE; Moesgaard SG; Kjelgaard-Hansen M; Rasmussen CE; Falk T; Fossing C; Häggström J; Pedersen HD; Olsen LH
Vet J; 2012 Apr; 192(1):106-11. PubMed ID: 21696985
[TBL] [Abstract][Full Text] [Related]
2. Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.
Rasmussen CE; Falk T; Zois NE; Moesgaard SG; Häggström J; Pedersen HD; Ablad B; Nilsen HY; Olsen LH
J Vet Intern Med; 2012; 26(1):76-84. PubMed ID: 22151356
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of pulmonary hypertension in Cavalier King Charles spaniels compared with other breeds with myxomatous mitral valve disease.
Sudunagunta S; Green D; Christley R; Dukes-McEwan J
J Vet Cardiol; 2019 Jun; 23():21-31. PubMed ID: 31174726
[TBL] [Abstract][Full Text] [Related]
4. R-R interval variations influence the degree of mitral regurgitation in dogs with myxomatous mitral valve disease.
Reimann MJ; Møller JE; Häggström J; Markussen B; Holen AE; Falk T; Olsen LH
Vet J; 2014 Mar; 199(3):348-54. PubMed ID: 24507881
[TBL] [Abstract][Full Text] [Related]
5. Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure.
Häggström J; Lord PF; Höglund K; Ljungvall I; Jöns O; Kvart C; Hansson K
J Vet Intern Med; 2013; 27(6):1452-62. PubMed ID: 24128373
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST study.
Häggström J; Boswood A; O'Grady M; Jöns O; Smith S; Swift S; Borgarelli M; Gavaghan B; Kresken JG; Patteson M; Åblad B; Bussadori CM; Glaus T; Kovačević A; Rapp M; Santilli RA; Tidholm A; Eriksson A; Belanger MC; Deinert M; Little CJ; Kvart C; French A; Rønn-Landbo M; Wess G; Eggertsdottir A; Lynne O'Sullivan M; Schneider M; Lombard CW; Dukes-McEwan J; Willis R; Louvet A; DiFruscia R
J Vet Intern Med; 2013; 27(6):1441-51. PubMed ID: 24010489
[TBL] [Abstract][Full Text] [Related]
7. Cytokine expression in peripheral blood mononuclear cells of dogs with mitral valve disease.
Mavropoulou A; Guazzetti S; Borghetti P; De Angelis E; Quintavalla C
Vet J; 2016 May; 211():45-51. PubMed ID: 27033593
[TBL] [Abstract][Full Text] [Related]
8. Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease.
Cremer SE; Singletary GE; Olsen LH; Wallace K; Häggström J; Ljungvall I; Höglund K; Reynolds CA; Pizzinat N; Oyama MA
J Vet Intern Med; 2014; 28(5):1534-40. PubMed ID: 25146933
[TBL] [Abstract][Full Text] [Related]
9. Plasma and serum serotonin concentrations and surface-bound platelet serotonin expression in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
Cremer SE; Kristensen AT; Reimann MJ; Eriksen NB; Petersen SF; Marschner CB; Tarnow I; Oyama MA; Olsen LH
Am J Vet Res; 2015 Jun; 76(6):520-31. PubMed ID: 26000599
[TBL] [Abstract][Full Text] [Related]
10. Markers of Oxidative Stress in Dogs with Myxomatous Mitral Valve Disease are Influenced by Sex, Neuter Status, and Serum Cholesterol Concentration.
Reimann MJ; Häggström J; Møller JE; Lykkesfeldt J; Falk T; Olsen LH
J Vet Intern Med; 2017 Mar; 31(2):295-302. PubMed ID: 28132441
[TBL] [Abstract][Full Text] [Related]
11. Increased serum C-reactive protein concentrations in dogs with congestive heart failure due to myxomatous mitral valve disease.
Reimann MJ; Ljungvall I; Hillström A; Møller JE; Hagman R; Falk T; Höglund K; Häggström J; Olsen LH
Vet J; 2016 Mar; 209():113-8. PubMed ID: 26831162
[TBL] [Abstract][Full Text] [Related]
12. Identification of 2 loci associated with development of myxomatous mitral valve disease in Cavalier King Charles Spaniels.
Madsen MB; Olsen LH; Häggström J; Höglund K; Ljungvall I; Falk T; Wess G; Stephenson H; Dukes-McEwan J; Chetboul V; Gouni V; Proschowsky HF; Cirera S; Karlskov-Mortensen P; Fredholm M
J Hered; 2011; 102 Suppl 1():S62-7. PubMed ID: 21846748
[TBL] [Abstract][Full Text] [Related]
13. Left Atrial Strain at Different Stages of Myxomatous Mitral Valve Disease in Dogs.
Nakamura K; Kawamoto S; Osuga T; Morita T; Sasaki N; Morishita K; Ohta H; Takiguchi M
J Vet Intern Med; 2017 Mar; 31(2):316-325. PubMed ID: 28145607
[TBL] [Abstract][Full Text] [Related]
14. Genetics of canine myxomatous mitral valve disease.
O'Brien MJ; Beijerink NJ; Wade CM
Anim Genet; 2021 Aug; 52(4):409-421. PubMed ID: 34028063
[TBL] [Abstract][Full Text] [Related]
15. Echocardiographic parameters for the assessment of congestive heart failure in dogs with myxomatous mitral valve disease and moderate to severe mitral regurgitation.
Morgan KRS; Monteith G; Raheb S; Colpitts M; Fonfara S
Vet J; 2020 Sep; 263():105518. PubMed ID: 32928487
[TBL] [Abstract][Full Text] [Related]
16. Flow-mediated vasodilation measurements in Cavalier King Charles Spaniels with increasing severity of myxomatous mitral valve disease.
Moesgaard SG; Klostergaard C; Zois NE; Teerlink T; Molin M; Falk T; Rasmussen CE; Luis Fuentes V; Jones ID; Olsen LH
J Vet Intern Med; 2012; 26(1):61-8. PubMed ID: 22151409
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of plasma and urinary levels of 6-keto-prostaglandin F1alpha as a marker for asymptomatic myxomatous mitral valve disease in dogs.
Rasmussen CE; Sundqvist AV; Kjempff CT; Tarnow I; Kjelgaard-Hansen M; Kamstrup TS; Sterup AL; Soerensen TM; Olsen LH
Vet J; 2010 May; 184(2):241-6. PubMed ID: 19324577
[TBL] [Abstract][Full Text] [Related]
18. Assessment of global and regional left ventricular volume and shape by real-time 3-dimensional echocardiography in dogs with myxomatous mitral valve disease.
Ljungvall I; Höglund K; Carnabuci C; Tidholm A; Häggström J
J Vet Intern Med; 2011; 25(5):1036-43. PubMed ID: 21848946
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of genes associated with human myxomatous mitral valve disease in dogs with familial myxomatous mitral valve degeneration.
Meurs KM; Friedenberg SG; Williams B; Keene BW; Atkins CE; Adin D; Aona B; DeFrancesco T; Tou S; Mackay T
Vet J; 2018 Feb; 232():16-19. PubMed ID: 29428085
[TBL] [Abstract][Full Text] [Related]
20. Rate of change of heart size before congestive heart failure in dogs with mitral regurgitation.
Lord P; Hansson K; Kvart C; Häggström J
J Small Anim Pract; 2010 Apr; 51(4):210-8. PubMed ID: 20406369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
